间歇性跛行患者下肢旁路术与腔内介入术后主要肢体不良事件和主要心脏不良事件的比较
该研究利用2011至2014年NSQIP血管靶向数据,比较间歇性跛行患者下肢旁路术(LEB)与腹股沟下腔内介入(IEI)后30天主要肢体不良事件(MALE)和主要心脏不良事件(MACE)。
要点
- 跛行患者LEB与IEI的30天MALE发生率无显著差异(4.0% vs 3.2%)。
- LEB组30天MACE显著高于IEI组(2.0% vs 1.0%),但死亡率相似。
- 胫动脉血运重建和既往同段旁路失败是MALE的预测因素。
核心结论
- 在大型国家队列中,跛行患者LEB与IEI的30天MALE相似。
- LEB与更高的30天MACE相关,但30天死亡率与IEI相当。
- 胫动脉血运重建和既往旁路失败后再次血运重建应谨慎进行。
研究设计与样本
- 使用2011至2014年NSQIP血管靶向参与者使用数据文件,纳入因跛行行LEB或IEI的患者。
- 共3925例腹股沟下血运重建手术,其中LEB 2155例,IEI 1770例。
- 主要结局为MALE(未处理的通畅性丧失、索引动脉段再干预或索引肢体截肢)和MACE(卒中、心肌梗死或死亡)。
- 采用多变量logistic回归识别MALE和MACE的预测因素。
临床怎么用
- 对跛行患者选择LEB或IEI时,应权衡LEB较高的30天MACE风险与长期结局。
- 对计划行胫动脉血运重建或既往旁路失败后再次血运重建的跛行患者,应谨慎评估MALE风险。
- 对终末期肾病、COPD和糖尿病患者,应警惕血运重建后MACE高风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Major adverse limb events (MALEs) and major adverse cardiovascular events (MACEs) at 30 days provide standardized metrics for comparison and have been adopted by the Society for Vascular Surgery's objective performance goals for critical limb ischemia. However, MALEs and MACEs have not been widely adopted within the claudication population, and the comparative outcomes after lower extremity bypass (LEB) and infrainguinal endovascular intervention (IEI) remain unclear. The purpose of this study was to compare MALEs and MACEs after LEB and IEI in a contemporary national cohort and to determine predictors of MALEs and MACEs after revascularization for claudication. METHODS: A national data set of LEB and IEI performed for claudication was obtained using National Surgical Quality Improvement Program vascular targeted Participant Use Data Files from 2011 to 2014. Patients were stratified by LEB vs IEI and compared by appropriate univariate analysis. The primary outcomes were MALE (defined as untreated loss of patency, reintervention on the index arterial segment, or amputation of the index limb) and MACE (defined as stroke, myocardial infarction, or death). Multivariable logistic regression was used to identify predictors of MALEs and MACEs. RESULTS: A total of 3925 infrainguinal revascularization procedures (2155 LEB and 1770 IEI) were performed for claudication. There was no difference in 30-day MALEs between LEB and IEI (4.0% vs 3.2%; P = .17). On multivariable logistic regression, predictors of 30-day MALEs included tibial revascularization (odds ratio [OR], 2.2; P < .0001) and prior LEB on the same arterial segment (OR, 1.8; P = .004). LEB had significantly higher 30-day MACEs (2.0% vs 1.0%; P = .01) but similar mortality (0.5% vs 0.4%; P = .6). Predictors of MACEs included LEB vs IEI (OR, 2.1; P = .01), chronic obstructive pulmonary disease (OR, 2.2; P = .01), dialysis dependence (OR, 4.4; P = .003), and diabetes (OR, 1.9; P = .02). CONCLUSIONS: In this large national cohort, LEB and IEI for claudication are associated with similar 30-day MALEs. Tibial revascularization and revascularization after prior failed bypass predict MALEs in claudicants and should therefore be undertaken with caution. LEB was associated with more 30-day MACEs but comparable 30-day mortality compared with IEI. Patients with end-stage renal disease, chronic obstructive pulmonary disease, and diabetes are at high risk for MACEs. The risk of 30-day MACEs after LEB should be weighed against the longer term outcomes of LEB vs IEI and conservative management, particularly in these higher risk patients. This analysis helps define contemporary 30-day outcomes after infrainguinal revascularization performed for claudication and serves as a baseline with which the short-term outcomes of future treatments can be compared.
引用
- Fashandi AZ, Mehaffey JH, Hawkins RB, et al. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication. J Vasc Surg. 2018. PMID: 30470369. doi:10.1016/j.jvs.2018.06.193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。